They exert their therapeutic effects by covalently binding reactive alkyl groups to cellular DNA, forming lethal interstrand or intrastrand cross-links that disrupt transcription, block replication, and trigger apoptosis in rapidly dividing cells.

Because their cytotoxic mechanism is largely cell-cycle non-specific, alkylating agents are widely indicated across a broad spectrum of malignancies, including leukemias, lymphomas, multiple myeloma, and various solid tumors such as breast, lung, ovarian, and brain cancers.

Major subclasses encompass nitrogen mustards, nitrosoureas, alkyl sulfonates, ethyleneimines, and triazines.

nih.gov
Alkylating agents are a major class of antineoplastic chemotherapeutic medications used in oncology and hematology They exert their therapeutic effects by covalently binding reactive alkyl groups to cellular DNA, forming lethal interstrand or intrastrand cross-links that disrupt transcription, block replication, and trigger apoptosis in rapidly dividing cells
nih.gov
Alkylating agents are a major class of antineoplastic chemotherapeutic medications used in oncology and hematology Because their cytotoxic mechanism is largely cell-cycle non-specific, alkylating agents are widely indicated across a broad spectrum of malignancies, including leukemias, lymphomas, multiple myeloma, and various solid tumors such as breast, lung, ovarian, and brain cancers
nih.gov
They exert their therapeutic effects by covalently binding reactive alkyl groups to cellular DNA, forming lethal interstrand or intrastrand cross-links that disrupt transcription, block replication, and trigger apoptosis in rapidly dividing cells
drugs.com
Because their cytotoxic mechanism is largely cell-cycle non-specific, alkylating agents are widely indicated across a broad spectrum of malignancies, including leukemias, lymphomas, multiple myeloma, and various solid tumors such as breast, lung, ovarian, and brain cancers Major subclasses encompass nitrogen mustards, nitrosoureas, alkyl sulfonates, ethyleneimines, and triazines
clemson.edu
Because their cytotoxic mechanism is largely cell-cycle non-specific, alkylating agents are widely indicated across a broad spectrum of malignancies, including leukemias, lymphomas, multiple myeloma, and various solid tumors such as breast, lung, ovarian, and brain cancers

Alkylating Agents

Drugs in Alkylating Agents

About Alkylating Agents.